Conceptualizing withdrawal-induced escalation of alcohol self-administration as a learned, plasticity-dependent process

Alcohol

Volumn 46, Issue 4, 2012, Pages 339-348

  Walker, Brendan M ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Anxiety; Dependence; Dynorphin; Extended Amygdala; Extracellular matrix; Kappa opioid receptor; Matrix metalloproteinase; Negative reinforcement; Nucleus accumbens; Stress

Indexed keywords

DYNORPHIN; KAPPA OPIATE RECEPTOR; MATRIX METALLOPROTEINASE;

ALCOHOL CONSUMPTION; ALCOHOL TOLERANCE; ALCOHOL WITHDRAWAL; ALCOHOLISM; AMYGDALOID NUCLEUS; DRINKING BEHAVIOR; DRUG SELF ADMINISTRATION; ENZYME INHIBITION; HUMAN; MESOLIMBIC DOPAMINERGIC SYSTEM; NONHUMAN; PHENOTYPE; REINFORCEMENT; REVIEW;

ALCOHOLISM; AMYGDALA; ANIMALS; DYNORPHINS; ETHANOL; HUMANS; MATRIX METALLOPROTEINASE INHIBITORS; NEURONAL PLASTICITY; RATS; RECEPTORS, OPIOID, KAPPA; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84861199710     PISSN: 07418329     EISSN: 18736823     Source Type: Journal    
DOI: 10.1016/j.alcohol.2012.01.001     Document Type: Review

References (126)

1. Amalric M., Cline E.J., Martinez J.L., Bloom F.E., Koob G.F. Rewarding properties of beta-endorphin as measured by conditioned place preference. Psychopharmacology (Berlin) 1987, 91:14-19.
2. American Psychiatric Association Diagnostic and statistical manual of mental disorders DSM-IV 1994, American Psychiatric Association, Washington, DC. 4th ed.
3. American Psychiatric Association Diagnostic and statistical manual of mental disorders DSM-IV-TR 2000, American Psychiatric Association, Washington, DC. 4th ed., text revision ed.
4. Anderson W.W., Thompson T. Ethanol self-administration in water satiated rats. Pharmacology Biochemistry and Behaviour 1974, 2:447-454.
5. Baldwin H.A., Rassnick S., Rivier J., Koob G.F., Britton K.T. CRF antagonist reverses the " anxiogenic" response to ethanol withdrawal in the rat. Psychopharmacology (Berlin) 1991, 103:227-232.
6. Bear M.F., Malenka R.C. Synaptic plasticity: LTP and LTD. Current Opinion in Neurobiology 1994, 4:389-399.
7. Becker H.C., Baros A.M. Effect of duration and pattern of chronic ethanol exposure on tolerance to the discriminative stimulus effects of ethanol in C57BL/6J mice. Journal of Pharmacology and Experimental Therapeutics 2006, 319:871-878.
8. Bozarth M.A. Evidence for the rewarding effects of ethanol using the conditioned place preference method. Pharmacology Biochemistry and Behaviour 1990, 35:485-487.
9. Broadwater M., Varlinskaya E.I., Spear L.P. Chronic intermittent ethanol exposure in early adolescent and adult male rats: effects on tolerance, social behavior, and ethanol intake. Alcoholism: Clinical and Experimental Research 2011, 35:1392-1403.
10. Brown T.E., Forquer M.R., Cocking D.L., Jansen H.T., Harding J.W., Sorg B.A. Role of matrix metalloproteinases in the acquisition and reconsolidation of cocaine-induced conditioned place preference. Learning & Memory 2007, 14:214-223.
11. Brown T.E., Forquer M.R., Harding J.W., Wright J.W., Sorg B.A. Increase in matrix metalloproteinase-9 levels in the rat medial prefrontal cortex after cocaine reinstatement of conditioned place preference. Synapse 2008, 62:886-889.
12. Brown T.E., Wilson A.R., Cocking D.L., Sorg B.A. Inhibition of matrix metalloproteinase activity disrupts reconsolidation but not consolidation of a fear memory. Neurobiology of Learning and Memory 2009, 91:66-72.
13. Carelli R.M. Nucleus accumbens cell firing during goal-directed behaviors for cocaine vs. 'natural' reinforcement. Physiology & Behaviour 2002, 76:379-387.
14. Carlezon W.A., Beguin C., DiNieri J.A., Baumann M.H., Richards M.R., Todtenkopf M.S., et al. Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats. Journal of Pharmacology and Experimental Therapeutics 2006, 316:440-447.
15. Carlezon W.A., Duman R.S., Nestler E.J. The many faces of CREB. Trends in Neurosciences 2005, 28:436-445.
16. Carr G.V., Bangasser D.A., Bethea T., Young M., Valentino R.J., Lucki I. Antidepressant-like effects of kappa-opioid receptor antagonists in wistar kyoto rats. Neuropsychopharmacology 2010, 35:752-763.
17. Carroll M.R., Rodd Z.A., Murphy J.M., Simon J.R. Chronic ethanol consumption increases dopamine uptake in the nucleus accumbens of high alcohol drinking rats. Alcohol 2006, 40:103-109.
18. Chen F., Lawrence A.J. Effect of chronic ethanol and withdrawal on the mu-opioid receptor- and 5-Hydroxytryptamine(1A) receptor-stimulated binding of [(35)S]Guanosine-5'-O-(3-thio)triphosphate in the fawn-hooded rat brain: a quantitative autoradiography study. Journal of Pharmacology and Experimental Therapeutics 2000, 293:159-165.
19. Di Chiara G., Bassareo V., Fenu S., De Luca M.A., Spina L., Cadoni C., et al. Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology 2004, 47(Suppl 1):227-241.
20. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proceedings of the National Academy of Sciences of the United States of America 1988, 85:5274-5278.
21. Dityatev A., Fellin T. Extracellular matrix in plasticity and epileptogenesis. Neuron Glia Biology 2008, 4:235-247.
22. Doyon W.M., Howard E.C., Shippenberg T.S., Gonzales R.A. Kappa-opioid receptor modulation of accumbal dopamine concentration during operant ethanol self-administration. Neuropharmacology 2006, 51:487-496.
23. Eckardt M.J., File S.E., Gessa G.L., Grant K.A., Guerri C., Hoffman P.L., et al. Effects of moderate alcohol consumption on the central nervous system. Alcoholism: Clinical and Experimental Research 1998, 22:998-1040.
24. Ethell I.M., Ethell D.W. Matrix metalloproteinases in brain development and remodeling: synaptic functions and targets. Journal of Neuroscience Research 2007, 85:2813-2823.
25. File S.E., Baldwin H.A., Hitchcott P.K. Flumazenil but not nitrendipine reverses the increased anxiety during ethanol withdrawal in the rat. Psychopharmacology (Berlin) 1989, 98:262-264.
26. Funk C.K., Dohrman D.P. Chronic ethanol exposure inhibits dopamine release via effects on the presynaptic actin cytoskeleton in PC12 cells. Brain Research 2007, 1185:86-94.
27. Funk C.K., O'Dell L.E., Crawford E.F., Koob G.F. Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. Journal of Neuroscience 2006, 26:11324-11332.
28. Gernert D. Ockham's razor and its improper use. Cognitive Systems 2009, 7:133-138.
29. Gianoulakis C., Krishnan B., Thavundayil J. Enhanced sensitivity of pituitary beta-endorphin to ethanol in subjects at high risk of alcoholism. Archives of General Psychiatry 1996, 53:250-257.
30. Harwood H.J., Fountain D., Livermore G. Economic costs of alcohol abuse and alcoholism. Recent Developments in Alcoholism 1998, 14:307-330.
31. Healey J.C., Winder D.G., Kash T.L. Chronic ethanol exposure leads to divergent control of dopaminergic synapses in distinct target regions. Alcohol 2008, 42:179-190.
32. Heilig M., Egli M. Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms. Pharmacology & Therapeutics 2006, 111:855-876.
33. Heilig M., Egli M., Crabbe J.C., Becker H.C. Acute withdrawal, protracted abstinence and negative affect in alcoholism: are they linked?. Addiction Biology 2010, 15:169-184.
34. Herz A. Endogenous opioid systems and alcohol addiction. Psychopharmacology (Berlin) 1997, 129:99-111.
35. Holmes M.V., Sen D. Microscopic polyangiitis and myasthenia gravis: the battle of Occam and Hickam. Clinical Rheumatology 2007, 26:1981-1983.
36. Hull E.M., Lorrain D.S., Du J., Matuszewich L., Lumley L.A., Putnam S.K., et al. Hormone-neurotransmitter interactions in the control of sexual behavior. Behavioural Brain Research 1999, 105:105-116.
37. Hyytia P., Kiianmaa K. Suppression of ethanol responding by centrally administered CTOP and naltrindole in AA and Wistar rats. Alcoholism: Clinical and Experimental Research 2001, 25:25-33.
38. Ikegami A., Duvauchelle C.L. Dopamine mechanisms and cocaine reward. International Review of Neurobiology 2004, 62:45-94.
39. Jarjour S., Bai L., Gianoulakis C. Effect of acute ethanol administration on the release of opioid peptides from the midbrain including the ventral tegmental area. Alcoholism: Clinical and Experimental Research 2009, 33:1033-1043.
40. Kalant H., LeBlanc A.E., Gibbins R.J. Tolerance to, and dependence on, some non-opiate psychotropic drugs. Pharmacological Reviews 1971, 23:135-191.
41. Kelley A.E., Bakshi V.P., Haber S.N., Steininger T.L., Will M.J., Zhang M. Opioid modulation of taste hedonics within the ventral striatum. Physiology & Behaviour 2002, 76:365-377.
42. Kelley A.E., Baldo B.A., Pratt W.E., Will M.J. Corticostriatal-hypothalamic circuitry and food motivation: integration of energy, action and reward. Physiology & Behaviour 2005, 86:773-795.
43. Koob G.F. Neurobiology of addiction. Toward the development of new therapies. Annals of the New York Academy of Sciences 2000, 909:170-185.
44. Koob G.F. A role for GABA mechanisms in the motivational effects of alcohol. Biochemical Pharmacology 2004, 68:1515-1525.
45. Koob G.F. Dynamics of neuronal circuits in addiction: reward, antireward, and emotional memory. Pharmacopsychiatry 2009, 42(Suppl 1):S32-S41.
46. Koob G.F. Neurobiological substrates for the dark side of compulsivity in addiction. Neuropharmacology 2009, 56(Suppl 1):18-31.
47. Koob G.F., Bloom F.E. Cellular and molecular mechanisms of drug dependence. Science 1988, 242:715-723.
48. Koob G.F., Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science 1997, 278:52-58.
49. Koob G.F., Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001, 24:97-129.
50. Koob G.F., Le Moal M. Addiction and the brain antireward system. Annual Review of Psychology 2008, 59:29-53.
51. Koob G.F., Weiss F. Neuropharmacology of cocaine and ethanol dependence. Recent Developments in Alcoholism 1992, 10:201-233.
52. Lam M.P., Marinelli P.W., Bai L., Gianoulakis C. Effects of acute ethanol on opioid peptide release in the central amygdala: an in vivo microdialysis study. Psychopharmacology (Berlin) 2008, 201:261-271.
53. Land B.B., Bruchas M.R., Lemos J.C., Xu M., Melief E.J., Chavkin C. The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system. Journal of Neuroscience 2008, 28:407-414.
54. Lee T.W., Tsang V.W., Birch N.P. Synaptic plasticity-associated proteases and protease inhibitors in the brain linked to the processing of extracellular matrix and cell adhesion molecules. Neuron Glia Biology 2008, 4:223-234.
55. Lessov C.N., Palmer A.A., Quick E.A., Phillips T.J. Voluntary ethanol drinking in C57BL/6J and DBA/2J mice before and after sensitization to the locomotor stimulant effects of ethanol. Psychopharmacology (Berlin) 2001, 155:91-99.
56. Lindholm S., Ploj K., Franck J., Nylander I. Repeated ethanol administration induces short- and long-term changes in enkephalin and dynorphin tissue concentrations in rat brain. Alcohol 2000, 22:165-171.
57. Logrip M.L., Janak P.H., Ron D. Dynorphin is a downstream effector of striatal BDNF regulation of ethanol intake. FASEB Journal 2008, 22:2393-2404.
58. Mague S.D., Pliakas A.M., Todtenkopf M.S., Tomasiewicz H.C., Zhang Y., Stevens W.C., et al. Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats. Journal of Pharmacology and Experimental Therapeutics 2003, 305:323-330.
59. Maldonado R. The neurobiology of addiction. Journal of Neural Transmission. Supplementum 2003, 1-14.
60. Margolis E.B., Hjelmstad G.O., Bonci A., Fields H.L. Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons. Journal of Neuroscience 2003, 23:9981-9986.
61. Margolis E.B., Lock H., Chefer V.I., Shippenberg T.S., Hjelmstad G.O., Fields H.L. Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:2938-2942.
62. Marinelli P.W., Lam M., Bai L., Quirion R., Gianoulakis C. A microdialysis profile of dynorphin A(1-8) release in the rat nucleus accumbens following alcohol administration. Alcoholism: Clinical and Experimental Research 2006, 30:982-990.
63. Marinelli P.W., Quirion R., Gianoulakis C. An in vivo profile of beta-endorphin release in the arcuate nucleus and nucleus accumbens following exposure to stress or alcohol. Neuroscience 2004, 127:777-784.
64. Markou A., Kosten T.R., Koob G.F. Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology 1998, 18:135-174.
65. Mash D.C., French-Mullen J., Adi N., Qin Y., Buck A., Pablo J. Gene expression in human hippocampus from cocaine abusers identifies genes which regulate extracellular matrix remodeling. PLoS ONE 2007, 2:e1187.
66. McBride W.J., Li T.K. Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents. Critical Reviews in Neurobiology 1998, 12:339-369.
67. McCool B.A. Ethanol modulation of synaptic plasticity. Neuropharmacology 2011, 61:1097-1108.
68. McCool B.A., Christian D.T., Diaz M.R., Lack A.K. Glutamate plasticity in the drunken amygdala: the making of an anxious synapse. International Review of Neurobiology 2010, 91:205-233.
69. McLaughlin J.P., Marton-Popovici M., Chavkin C. Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses. Journal of Neuroscience 2003, 23:5674-5683.
70. Meighan P.C., Meighan S.E., Davis C.J., Wright J.W., Harding J.W. Effects of matrix metalloproteinase inhibition on short- and long-term plasticity of schaffer collateral/CA1 synapses. Journal of Neurochemistry 2007, 102:2085-2096.
71. Meighan S.E., Meighan P.C., Choudhury P., Davis C.J., Olson M.L., Zornes P.A., et al. Effects of extracellular matrix-degrading proteases matrix metalloproteinases 3 and 9 on spatial learning and synaptic plasticity. Journal of Neurochemistry 2006, 96:1227-1241.
72. Mitchell J.M., Liang M.T., Fields H.L. A single injection of the kappa opioid antagonist norbinaltorphimine increases ethanol consumption in rats. Psychopharmacology (Berlin) 2005, 182:384-392.
73. Mizoguchi H., Yamada K., Niwa M., Mouri A., Mizuno T., Noda Y., et al. Reduction of methamphetamine-induced sensitization and reward in matrix metalloproteinase-2 and -9-deficient mice. Journal of Neurochemistry 2007, 100:1579-1588.
74. Mokdad A.H., Marks J.S., Stroup D.F., Gerberding J.L. Actual causes of death in the United States, 2000. Journal of the American Medical Association 2004, 291:1238-1245.
75. Mucha R.F., Herz A. Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning. Psychopharmacology (Berlin) 1985, 86:274-280.
76. Nagy V., Bozdagi O., Huntley G.W. The extracellular protease matrix metalloproteinase-9 is activated by inhibitory avoidance learning and required for long-term memory. Learning & Memory 2007, 14:655-664.
77. Nagy V., Bozdagi O., Matynia A., Balcerzyk M., Okulski P., Dzwonek J., et al. Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory. Journal of Neuroscience 2006, 26:1923-1934.
78. Nealey K.A., Smith A.W., Davis S.M., Smith D.G., Walker B.M. kappa-opioid receptors are implicated in the increased potency of intra-accumbens nalmefene in ethanol-dependent rats. Neuropharmacology 2011, 61:35-42.
79. Nestler E.J. Cellular responses to chronic treatment with drugs of abuse. Critical Reviews in Neurobiology 1993, 7:23-39.
80. Nestler E.J., Carlezon W.A. The mesolimbic dopamine reward circuit in depression. Biological Psychiatry 2006, 59:1151-1159.
81. Nylander I., Vlaskovska M., Terenius L. Brain dynorphin and enkephalin systems in Fischer and Lewis rats: effects of morphine tolerance and withdrawal. Brain Research 1995, 683:25-35.
82. O'Dell L.E., Roberts A.J., Smith R.T., Koob G.F. Enhanced alcohol self-administration after intermittent versus continuous alcohol vapor exposure. Alcoholism: Clinical and Experimental Research 2004, 28:1676-1682.
83. Olson M.L., Meighan P.C., Brown T.E., Asay A.L., Benoist C.C., Harding J.W., et al. Hippocampal MMP-3 elevation is associated with passive avoidance conditioning. Regulatory Peptides 2008, 146:19-25.
84. Ortiz J., Fitzgerald L.W., Charlton M., Lane S., Trevisan L., Guitart X., et al. Biochemical actions of chronic ethanol exposure in the mesolimbic dopamine system. Synapse 1995, 21:289-298.
85. Pfeiffer A., Brantl V., Herz A., Emrich H.M. Psychotomimesis mediated by kappa opiate receptors. Science 1986, 233:774-776.
86. Pliakas A.M., Carlson R.R., Neve R.L., Konradi C., Nestler E.J., Carlezon W.A. Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. Journal of Neuroscience 2001, 21:7397-7403.
87. Przewlocka B., Turchan J., Lason W., Przewlocki R. Ethanol withdrawal enhances the prodynorphin system activity in the rat nucleus accumbens. Neuroscience Letters 1997, 238:13-16.
88. Roberts A.J., Cole M., Koob G.F. Intra-amygdala muscimol decreases operant ethanol self-administration in dependent rats. Alcoholism: Clinical and Experimental Research 1996, 20:1289-1298.
89. Roberts A.J., Heyser C.J., Cole M., Griffin P., Koob G.F. Excessive ethanol drinking following a history of dependence: animal model of allostasis. Neuropsychopharmacology 2000, 22:581-594.
90. Rogers J., Wiener S.G., Bloom F.E. Long-term ethanol administration methods for rats: advantages of inhalation over intubation or liquid diets. Behavioral and Neural Biology 1979, 27:466-486.
91. Rosin A., Lindholm S., Franck J., Georgieva J. Downregulation of kappa opioid receptor mRNA levels by chronic ethanol and repetitive cocaine in rat ventral tegmentum and nucleus accumbens. Neuroscience Letters 1999, 275:1-4.
92. Saland L.C., Abeyta A., Frausto S., Raymond-Stintz M., Hastings C.M., Carta M., et al. Chronic ethanol consumption reduces delta-and mu-opioid receptor-stimulated G-protein coupling in rat brain. Alcoholism: Clinical and Experimental Research 2004, 28:98-104.
93. Samochowiec A., Grzywacz A., Kaczmarek L., Bienkowski P., Samochowiec J., Mierzejewski P., et al. Functional polymorphism of matrix metalloproteinase-9 (MMP-9) gene in alcohol dependence: family and case control study. Brain Research 2010, 1327:103-106.
94. Schattner A. As sharp as Occam?. Lancet 2009, 373:1996.
95. Schulteis G., Markou A., Cole M., Koob G.F. Decreased brain reward produced by ethanol withdrawal. Proceedings of the National Academy of Sciences of the United States of America 1995, 92:5880-5884.
96. Shippenberg T.S., Bals-Kubik R., Herz A. Motivational properties of opioids: evidence that an activation of delta-receptors mediates reinforcement processes. Brain Research 1987, 436:234-239.
97. Shippenberg T.S., Herz A. Differential effects of mu and kappa opioid systems on motivational processes. NIDA Research Monographs 1986, 75:563-566.
98. Shirayama Y., Ishida H., Iwata M., Hazama G.I., Kawahara R., Duman R.S. Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects. Journal of Neurochemistry 2004, 90:1258-1268.
99. Siegelbaum S.A., Kandel E.R. Learning-related synaptic plasticity: LTP and LTD. Current Opinion in Neurobiology 1991, 1:113-120.
100. Siggins G.R., Martin G., Roberto M., Nie Z., Madamba S., De L.L. Glutamatergic transmission in opiate and alcohol dependence. Annals of the New York Academy of Sciences 2003, 1003:196-211.
101. Sillanaukee P., Kalela A., Seppa K., Hoyhtya M., Nikkari S.T. Matrix metalloproteinase-9 is elevated in serum of alcohol abusers. European Journal of Clinical Investigation 2002, 32:225-229.
102. Smith A.W., Nealey K.A., Wright J.W., Walker B.M. Plasticity associated with escalated operant ethanol self-administration during acute withdrawal in ethanol-dependent rats requires intact matrix metalloproteinase systems. Neurobiology of Learning and Memory 2011, 96:199-206.
103. Smith S.G., Davis W.M. Intravenous alcohol self-administration in the rat. Pharmacological Research Communications 1974, 6:379-402.
104. Solomon R.L., Corbit J.D. An opponent-process theory of motivation. I. Temporal dynamics of affect. Psychological Review 1974, 81:119-145.
105. Spanagel R., Herz A., Shippenberg T.S. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proceedings of the National Academy of Sciences of the United States of America 1992, 89:2046-2050.
106. Sperling R.E., Gomes S.M., Sypek E.I., Carey A.N., McLaughlin J.P. Endogenous kappa-opioid mediation of stress-induced potentiation of ethanol-conditioned place preference and self-administration. Psychopharmacology (Berlin) 2010, 210:199-209.
107. Stromberg M.F., Casale M., Volpicelli L., Volpicelli J.R., O'Brien C.P. A comparison of the effects of the opioid antagonists naltrexone, naltrindole, and beta-funaltrexamine on ethanol consumption in the rat. Alcohol 1998, 15:281-289.
108. Substance Abuse and Mental Health Services Administration Results from the 2009 national survey on drug use and health 2010, Office of Applied Studies, DHHS Publication, Rockville, MD.
109. Svingos A.L., Colago E.E., Pickel V.M. Cellular sites for dynorphin activation of kappa-opioid receptors in the rat nucleus accumbens shell. Journal of Neuroscience 1999, 19:1804-1813.
110. Todtenkopf M.S., Marcus J.F., Portoghese P.S., Carlezon W.A. Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats. Psychopharmacology (Berlin) 2004, 172:463-470.
111. Turchan J., Przewlocka B., Toth G., Lason W., Borsodi A., Przewlocki R. The effect of repeated administration of morphine, cocaine and ethanol on mu and delta opioid receptor density in the nucleus accumbens and striatum of the rat. Neuroscience 1999, 91:971-977.
112. Valdez G.R., Roberts A.J., Chan K., Davis H., Brennan M., Zorrilla E.P., et al. Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. Alcoholism: Clinical and Experimental Research 2002, 26:1494-1501.
113. Walker B.M., Drimmer D.A., Walker J.L., Liu T., Mathe A.A., Ehlers C.L. Effects of prolonged ethanol vapor exposure on forced swim behavior, and neuropeptide Y and corticotropin-releasing factor levels in rat brains. Alcohol 2010, 44:487-493.
114. Walker B.M., Ettenberg A. Intracerebroventricular ethanol-induced conditioned place preferences are prevented by fluphenazine infusions into the nucleus accumbens of rats. Behavioral Neuroscience 2007, 121:401-410.
115. Walker B.M., Koob G.F. The gamma-aminobutyric acid-B receptor agonist baclofen attenuates responding for ethanol in ethanol-dependent rats. Alcoholism: Clinical and Experimental Research 2007, 31:11-18.
116. Walker B.M., Koob G.F. Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence. Neuropsychopharmacology 2008, 33:643-652.
117. Walker B.M., Valdez G.R., McLaughlin J.P., Bakalkin G. Targeting Dynorphin/Kappa Opioid Receptor Systems to Treat Alcohol Abuse and Dependence. Alcohol 2012, in press.
118. Walker B.M., Zorrilla E.P., Koob G.F. Systemic kappa-opioid receptor antagonism by nor-binaltorphimine reduces dependence-induced excessive alcohol self-administration in rats. Addiction Biology 2011, 16:116-119.
119. Wang X.B., Bozdagi O., Nikitczuk J.S., Zhai Z.W., Zhou Q., Huntley G.W. Extracellular proteolysis by matrix metalloproteinase-9 drives dendritic spine enlargement and long-term potentiation coordinately. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:19520-19525.
120. Wheeler R.A., Carelli R.M. Dissecting motivational circuitry to understand substance abuse. Neuropharmacology 2009, 56(Suppl 1):149-159.
121. Wiediger R.V., Wright J.W. Influence of dorsal hippocampal lesions and MMP inhibitors on spontaneous recovery following a habituation/classical conditioning head-shake task. Neurobiology of Learning and Memory 2009, 92:504-511.
122. Williams A.M., Reis D.J., Powell A.S., Neira L.J., Nealey K.A., Ziegler C.E. The effect of intermittent alcohol vapor or pulsatile heroin on somatic and negative affective indices during spontaneous withdrawal in wistar rats. Psychopharmacology 2012, in press.
123. Williams K.L., Woods J.H. Oral ethanol-reinforced responding in rhesus monkeys: effects of opioid antagonists selective for the mu-, kappa-, or delta-receptor. Alcoholism: Clinical and Experimental Research 1998, 22:1634-1639.
124. Wright J.W., Brown T.E., Harding J.W. Inhibition of hippocampal matrix metalloproteinase-3 and -9 disrupts spatial memory. Neural Plasticity 2007, 2007:73813.
125. Wright J.W., Harding J.W. The brain angiotensin system and extracellular matrix molecules in neural plasticity, learning, and memory. Progress in Neurobiology 2004, 72:263-293.
126. Wright J.W., Harding J.W. Contributions of matrix metalloproteinases to neural plasticity, habituation, associative learning and drug addiction. Neural Plasticity 2009, 2009:579382.